LENSAR Stock-Based Compensation 2019-2024 | LNSR
LENSAR stock-based compensation from 2019 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| LENSAR Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $3 |
| 2023 | $6 |
| 2022 | $7 |
| 2021 | $7 |
| 2020 | $9 |
| 2019 | $0 |
| 2018 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.165B | $0.053B |
| LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. | |||